MentionFox
Home › Executive changes › Vitaspring Biomedical Co. Ltd.
Leadership changes · SEC Form 8-K, Item 5.02

Vitaspring Biomedical Co. Ltd. executive changes

Every leadership change Vitaspring Biomedical Co. Ltd. reported to the SEC under Item 5.02: who left, who was appointed, to what role and from when, quoted from each filing.

Filings1
Appointments named2
Departures named1
Latest filing2026-09-10

Vitaspring Biomedical Co. Ltd. filed 1 current report with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-09-10. Between them they name 3 people, with 2 appointments and 1 departure. Each change below is quoted from the filing and linked to it.

Every change, newest first

Filed 2026-09-10 · 8-K

Departing: Chuan Lai, Chief Executive Officer

Pacific Time on September 7, 2026, immediately following the election of her successor as a director and the appointment of her successor officers as described in Items 5.02(c) and (d) below, Dr. Ssu-Chuan Lai resigned from her positions as Chairperson of the Board, Chief Executive Officer, President, Chief Financial Officer, and Secretary of the Company, and as a member of the Board.

Appointed: Zhou Chen

The Board designated Mr. Chen as the Company's principal executive officer and as its principal financial officer and principal accounting officer.

Appointed: Hsiang Shih, Chairman of the Board

Pacific Time on September 7, 2026, Mr. Shih was appointed Chairman of the Board, to serve at the pleasure of the Board.
Hiring for a seat like this?

Find people with the same kind of experience as the Chief Executive Officer at Vitaspring Biomedical Co. Ltd., with the record behind each one.

Find candidates like Chief Executive Officer at Vitaspring Biomedical Co. Ltd.
Selling to Vitaspring Biomedical Co. Ltd.?

New leaders review vendors and budgets in their first months. Get an alert the next time Vitaspring Biomedical Co. Ltd. is in the news or changes leadership.

Get an alert when Vitaspring Biomedical Co. Ltd. changes leadership

Tools for this story

Each opens in a new tab, filled in for Vitaspring Biomedical Co. Ltd.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/vitaspring-biomedical-co
Last updated 2026-09-27
Primary record: SEC filing
Vitaspring Biomedical Co. Ltd. (VSBC) executive changes: Chuan Lai departs, Chief Executive Officer. MentionFox, 2026-09-27. https://mentionfox.com/executive-changes/vitaspring-biomedical-co